GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of the Netherlands: state board, and what it actually costs here — 35 comments in the full submission. View in context.
5.3k
c/compounding·submitted 2 years ago by u/rekha_mwangi

the Netherlands: state board, and what it actually costs here

Questionbranch of 8 comments

the Netherlands: state board, and what it actually costs here — a position I have arrived at slowly and would like tested. Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label. Asked which facility and got a…

Read the full submission and all 35 comments →

This branch

8 comments, started 2 years ago
u/solene_eriksen128 points·2 years ago

The intake asked me three questions and none of them were about my history. That told me everything I needed to know about the model.

replysharereportpermalink
u/anya_antonsen48 points·2 years ago

Push back: "compounded is fine because a pharmacy made it" skips every question this board exists to ask.

replysharereportpermalink
u/bilal_osei70 points·2 years ago

a 503B has to register and report, so there is a paper trail to ask for

replysharereportpermalink
u/rafael_ostergaard27 points·2 years ago

This. Compounded preparations carry no equivalence claim, and treating them as generics is a category error people make constantly.

replysharereportpermalink
u/rekha_mwangiOP20 points·2 years ago

This.

Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.

replysharereportpermalink
u/enzo_ferrari15 points·2 years ago

That figure is the starting material purity, not the finished preparation potency. Two different tests.

replysharereportpermalink
u/runa_grimaldi16 points·2 years ago

the shortage list is the whole legal hinge and people skip it

replysharereportpermalink
u/rekha_mwangiOP6 points·2 years ago

Kept the label from every vial. When the shortage status changed, having the paper trail made the conversation much shorter.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.